Carafate and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Carafate (sucralfate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Gabapentin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Carafate. It is created by eHealthMe based on reports of 13,583 people who have side effects when taking Carafate from the FDA, and is updated regularly.

What is Carafate?

Carafate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 14,028 Carafate users. Check the latest studies of Carafate.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

On Aug, 11, 2026

13,583 people reported to have side effects when taking Carafate.
Among them, 17 people (0.13%) have Common peroneal nerve dysfunction.

Could Carafate cause Common peroneal nerve dysfunction?

Among these 17 people:

How long have people been on Carafate when they have Common peroneal nerve dysfunction? *

What is the gender of people who have Common peroneal nerve dysfunction when taking Carafate? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Common peroneal nerve dysfunction when taking Carafate? *

What are other drugs people take besides Carafate? *

What are other side effects people have besides Common peroneal nerve dysfunction? *

Fatigue (feeling of tiredness): 13 people, 76.47%
Stress And Anxiety: 12 people, 70.59%
Fall: 11 people, 64.71%
Intervertebral Disc Protrusion (spinal disc protrusion): 11 people, 64.71%
Headache (pain in head): 11 people, 64.71%
Anaemia (lack of blood): 11 people, 64.71%
Cellulitis (infection under the skin): 11 people, 64.71%
Depression: 10 people, 58.82%
Diarrhea: 10 people, 58.82%
Gait Disturbance: 10 people, 58.82%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 52.94%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 29.41%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 11.76%
Gastric Disorder (disease of stomach): 2 people, 11.76%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 11.76%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 11.76%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
Herpes Virus Infection: 1 person, 5.88%
Gait Disturbance: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Carafate and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carafate:

Carafate (14,028 reports)

Browse all side effects of Carafate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (651 drugs)

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (1,130 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sucralfate (the active ingredients of Carafate) and Carafate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.